April, 15, 2025 — Optellum  has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and precision lung cancer care. Under the agreement, Optellum will apply its AI-powered imaging and clinical decision support platform to evaluate the real-world impact on patient outcomes.

April 15, 2025 — CureMetrix, a provider of AI-driven medical imaging solutions, has announced that its AI-based cmAngio software received FDA clearance for use with GE Healthcare mammography imaging platforms.

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 with a CAGR of 4.6%.

April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect early signs of tricuspid heart valve disease and may help doctors diagnose and treat patients sooner, according to research from the 

April 3, 2025 – Konica Minolta Healthcare Americas, Inc. has launched the next-generation of the Exa Platform with the most advanced version of Exa PACS|RIS released to date, featuring a new API platform designed to integrate with strategic partners.

April 15, 2025 — Eric Grunden has joined Intelerad as chief customer officer. In this role, Grunden will lead initiatives to enhance the client experience, improve support systems, and drive operational excellence across all client-facing teams. His leadership will ensure improved service delivery, strengthen client relationships, and support healthcare providers in realizing lasting value from Intelerad’s solutions.

April 14, 2025 —The Society for Imaging Informatics in Medicine (SIIM) Annual Meeting is set to take place May 23 to 25, 2025 in Portland, Oregon.

April 11, 2025 — Contrast-enhanced ultrasound (CEUS) is a safe and accurate diagnostic imaging option for pregnant women who develop a medical problem or a suspicious tumor that typically would be investigated by a contrast enhanced CT or MR scan, according to a new study by Canadian doctors.

April 3, 2025 – Accuray Inc. recently announced  that new data on the clinical use of the CyberKnife System reinforce the device’s broad-based radiation treatment capabilities for central nervous system (CNS) tumors. Malignant brain and other CNS tumors are considered to be some of the most fatal types of cancer and contribute to significant morbidity and mortality in the United States1.

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving clinical and technical research to advance innovation for pediatric care delivery across modalities, including magnetic resonance imaging (MRI), ultrasound, molecular imaging (MI) and computed tomography (CT).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now